-
IMM · UTC · Smilegate, "The largest" with 3 IPO portfolios
According to the The Bell survey, a total of 45 venture capitals succeeded in IPO more than one investment portfolio. In particular, IMM Investment, UTC Investment, and Smilegate Investment are believed to have IPO three portfolio companies on the KOSDAQ
-
UTC Investment, "Building a bio, retail, and IT triangle formation"
For UTC Investment, 2021 is expected to mark a single year of investing in the bio sector. Aggressive fund formation, investment, and stable recovery were balanced. In particular, it has increased its presence in the bio-investment industry by forming a large bio-venture fund worth more than 100 billion won.
-
Sea-yeon Kim, CEO of UTC Investment, said,
UTC Investment is a venture capital that succeeds in investing in Immunmed and Engenbio and shows noticeable results in the bio sector. It is also recognized for its ability by operating specialized funds in retail and ICT sector. Since taking office as CEO of VC in April this year, CEO Sea-yeon Kim has been making great efforts to establish UTC's investment philosophy and brand
-
UTC Investment secures additional ammunition for large bio funds
UTC Investment will push for an increase in bio venture funds worth 125 billion won formed last month. Following the recent securing of 10 billion won in ammunition, it is discussing raising 5 billion won worth of additional funds. If there are no special variables, it plans to multi-closing worth 140 billion won within this year.
-
Military Mutual Aid Association selected blind fund management company
The Military Mutual Aid Association has finalized a private equity alternative blind fund investment company. While a number of management companies that have stood out in beauty contests of pension funds and mutual aid associations have been included, newly named places are also attracting attention. The Military Mutual Aid Association announced on the 14th that it has selected 18 domestic blind fund operators in 2021
-
UTC Investment strengthens expertise by expanding manpower.
UTC Investment, which advocates a bio-specialized venture capital (VC), has recently expanded its investment manpower. It has strengthened its house capabilities by transfusing bio-specialist from the industry and veteran general investment personnel. On top of that, one more new employee from KAIST has been selected to reinforce the number of employees
-
Korea Investment Partners and UTC Investment recorded "the largest" with six investments.
Venture capital (VC), which showed the most active movement in the private pharmaceutical bio-funding market in the third quarter of this year, was Korea Investment Partners and UTC Investment. Based on the number of investments, the top VCs joined forces to bet mainly on early biotechs equipped with new infrastructure technologies.
-
The Yellow Umbrella Mutual Aid Association has selected 10 VC fund operators of 120 billion won
Yellow Umbrella Mutual Aid Association, run by the KBIZ, has selected 10 investment management companies to operate VC funds worth 120 billion won for the growth and development of small and medium-sized venture companies.
-
Follow-up investment · HR support · business expansion after IPO and Value-up
UTC Investment, a VC affiliated with the Daesang group established in 1988, has made a "debs" investment through top-down analysis. Capital gain is not the only purpose. It will continue to make follow-on investments at each stage of corporate growth to help IPO and participate in subsequent capital increase.
-
UTC Investment Strengthens 'Advanced Investment' Strategy
UTC Investment's detailed investment strategy, which has been strengthening investment in the bio-healthcare sector this year, is drawing attention. The goal is to advance from a wide range of bio and healthcare investments to focus on project-like investments in detailed areas with high potential for future growth.